Laboratory Corp Of America (LH) EBITDA (2008 - 2026)
Laboratory Corp Of America (LH) EBITDA from Jun 30, 2008 to Mar 31, 2026. The TTM Laboratory Corp Of America (LH) EBITDA is $2.13B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Laboratory Corp Of America (LH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +21.74% |
| 3 Years TTM | +10.04% |
| 5 Years TTM | -13.37% |
| 10 Years TTM | +2.63% |
| All Time TTM | +7.13% |
Annual EBITDA change of Laboratory Corp Of America (LH)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $554M | -73.18% |
| 2025 | $2.07B | +19.40% |
| 2024 | $1.73B | +32.80% |
| 2023 | $1.30B | -33.99% |
| 2022 | $1.97B | -45.56% |
| 2021 | $3.63B | +18.09% |
| 2020 | $3.07B | +60.96% |
| 2019 | $1.91B | +1.58% |
| 2018 | $1.88B | +2.14% |
| 2017 | $1.84B | +3.88% |
| 2016 | $1.77B | +21.67% |
| 2015 | $1.45B | +25.84% |
| 2014 | $1.16B | -5.33% |
| 2013 | $1.22B | -2.58% |
| 2012 | $1.25B | +6.23% |
| 2011 | $1.18B | -0.22% |
| 2010 | $1.18B | +4.54% |
| 2009 | $1.13B | +10.60% |
| 2008 | $1.02B | +8.81% |
| 2007 | $940M | N/A |
Comparison Laboratory Corp Of America (LH) five years EBITDA CAGR with competitors
Laboratory Corp Of America (LH) five years EBITDA CAGR is -13.37%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | -647.08% |
| MEDP | Medpace Holdings Inc | 25.16% | -288.17% |
| ISPC | iSpecimen Inc | 25.14% | -288.00% |
| PSNL | Personalis Inc | 18.83% | -240.80% |
| WAT | Waters Corp | 17.45% | -230.53% |
| BNR | Burning Rock Biotech Ltd | 17.26% | -229.09% |
| ICLR | Icon Plc | 12.53% | -193.73% |
| IDXX | Idexx Laboratories Inc | 11.66% | -187.23% |
| CSTL | Castle Biosciences Inc | 10.29% | -176.94% |
| MTD | Mettler-Toledo International Inc | 9.87% | -173.80% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -173.44% |
| IQV | IQVIA Holdings Inc | 9.14% | -168.38% |
| RDNT | Radnet Inc | 8.38% | -162.71% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -156.95% |
| A | Agilent Technologies Inc | 6.59% | -149.27% |
| ILMN | Illumina Inc | 5.98% | -144.74% |
| GH | Guardant Health Inc | 5.67% | -142.41% |
| NTRA | Natera Inc | 3.35% | -125.06% |
| TWST | Twist Bioscience Corp | 2.84% | -121.23% |
| BDSX | Biodesix Inc | 2.43% | -118.20% |
| SHC | Sotera Health Company | 2.32% | -117.36% |
| QGEN | Qiagen NV | 2.21% | -116.49% |